166 related articles for article (PubMed ID: 31756254)
1. Posttreatment Intervention With Lycium Barbarum Polysaccharides is Neuroprotective in a Rat Model of Chronic Ocular Hypertension.
Lakshmanan Y; Wong FSY; Zuo B; So KF; Bui BV; Chan HH
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4606-4618. PubMed ID: 31756254
[TBL] [Abstract][Full Text] [Related]
2. Lycium Barbarum Polysaccharides Rescue Neurodegeneration in an Acute Ocular Hypertension Rat Model Under Pre- and Posttreatment Conditions.
Lakshmanan Y; Wong FS; Yu WY; Li SZ; Choi KY; So KF; Chan HH
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2023-2033. PubMed ID: 31067322
[TBL] [Abstract][Full Text] [Related]
3. Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension.
Mi XS; Feng Q; Lo AC; Chang RC; Lin B; Chung SK; So KF
PLoS One; 2012; 7(10):e45469. PubMed ID: 23094016
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal outcomes of circumlimbal suture model-induced chronic ocular hypertension in Sprague-Dawley albino rats.
Lakshmanan Y; Wong FSY; Zuo B; Bui BV; Chan HH
Graefes Arch Clin Exp Ophthalmol; 2020 Dec; 258(12):2715-2728. PubMed ID: 32623578
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
[TBL] [Abstract][Full Text] [Related]
6. A Mouse Model of Chronic Ocular Hypertension Induced by Circumlimbal Suture.
Liu HH; Flanagan JG
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):353-361. PubMed ID: 28118662
[TBL] [Abstract][Full Text] [Related]
7. Reversal of functional loss in a rat model of chronic intraocular pressure elevation.
Liu HH; He Z; Nguyen CT; Vingrys AJ; Bui BV
Ophthalmic Physiol Opt; 2017 Jan; 37(1):71-81. PubMed ID: 27774623
[TBL] [Abstract][Full Text] [Related]
8. Chronic ocular hypertension induced by circumlimbal suture in rats.
Liu HH; Bui BV; Nguyen CT; Kezic JM; Vingrys AJ; He Z
Invest Ophthalmol Vis Sci; 2015 May; 56(5):2811-20. PubMed ID: 25829414
[TBL] [Abstract][Full Text] [Related]
9. Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension.
Sandalon S; Könnecke B; Levkovitch-Verbin H; Simons M; Hein K; Sättler MB; Bähr M; Ofri R
Exp Eye Res; 2013 Oct; 115():47-56. PubMed ID: 23810807
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Elevated Intraocular Pressure and Divided Peripapillary Sector Retinal Nerve Fiber Layer Thickness in a Cynomolgus Monkey Laser-Induced Ocular Hypertension Model.
Noguchi T; Shimazawa M; Hamaguchi K; Araki T; Horai N; Hara H
Ophthalmic Res; 2017; 58(2):99-106. PubMed ID: 28564657
[TBL] [Abstract][Full Text] [Related]
11. Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension.
Alsarraf O; Fan J; Dahrouj M; Chou CJ; Yates PW; Crosson CE
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7486-93. PubMed ID: 25358731
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of Retinal Ganglion Cell Dysfunction From Chronic IOP Elevation.
Zhao D; Wong VHY; Nguyen CTO; Jobling AI; Fletcher EL; Vingrys AJ; Bui BV
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3878-3886. PubMed ID: 31529082
[TBL] [Abstract][Full Text] [Related]
15. Progressive degeneration of retinal and superior collicular functions in mice with sustained ocular hypertension.
Chen H; Zhao Y; Liu M; Feng L; Puyang Z; Yi J; Liang P; Zhang HF; Cang J; Troy JB; Liu X
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1971-84. PubMed ID: 25722210
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model.
Emre E; Yüksel N; Duruksu G; Pirhan D; Subaşi C; Erman G; Karaöz E
Cytotherapy; 2015 May; 17(5):543-59. PubMed ID: 25618560
[TBL] [Abstract][Full Text] [Related]
17. Deformation of the rodent optic nerve head and peripapillary structures during acute intraocular pressure elevation.
Fortune B; Choe TE; Reynaud J; Hardin C; Cull GA; Burgoyne CF; Wang L
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6651-61. PubMed ID: 21730343
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats.
Abbott CJ; Choe TE; Lusardi TA; Burgoyne CF; Wang L; Fortune B
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):674-87. PubMed ID: 24398096
[TBL] [Abstract][Full Text] [Related]
19. A modified chronic ocular hypertension rat model for retinal ganglion cell neuroprotection.
Zhong L
Front Med; 2013 Sep; 7(3):367-77. PubMed ID: 23740109
[TBL] [Abstract][Full Text] [Related]
20. Pigmented and albino rats differ in their responses to moderate, acute and reversible intraocular pressure elevation.
Gurdita A; Tan B; Joos KM; Bizheva K; Choh V
Doc Ophthalmol; 2017 Jun; 134(3):205-219. PubMed ID: 28389912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
